These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39028815)

  • 21. RNA Polymerase II Promoter-Proximal Pausing and Release to Elongation Are Key Steps Regulating Herpes Simplex Virus 1 Transcription.
    Birkenheuer CH; Baines JD
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
    Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
    Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal regions associated with prostate cancer risk localize to lamin B-deficient microdomains and exhibit reduced gene transcription.
    Helfand BT; Wang Y; Pfleghaar K; Shimi T; Taimen P; Shumaker DK
    J Pathol; 2012 Apr; 226(5):735-45. PubMed ID: 22025297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers.
    Makkonen H; Kauhanen M; Paakinaho V; Jääskeläinen T; Palvimo JJ
    Nucleic Acids Res; 2009 Jul; 37(12):4135-48. PubMed ID: 19433513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.
    Rajabi H; Ahmad R; Jin C; Joshi MD; Guha M; Alam M; Kharbanda S; Kufe D
    Prostate; 2012 Nov; 72(15):1659-68. PubMed ID: 22473899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupeol, a novel androgen receptor inhibitor: implications in prostate cancer therapy.
    Siddique HR; Mishra SK; Karnes RJ; Saleem M
    Clin Cancer Res; 2011 Aug; 17(16):5379-91. PubMed ID: 21712449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling truncated AR expression in a natural androgen responsive environment and identification of RHOB as a direct transcriptional target.
    Tsai HC; Boucher DL; Martinez A; Tepper CG; Kung HJ
    PLoS One; 2012; 7(11):e49887. PubMed ID: 23209612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.
    Chellini L; Pieraccioli M; Sette C; Paronetto MP
    J Exp Clin Cancer Res; 2022 May; 41(1):178. PubMed ID: 35590370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.
    Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS
    Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.
    Haffner MC; Aryee MJ; Toubaji A; Esopi DM; Albadine R; Gurel B; Isaacs WB; Bova GS; Liu W; Xu J; Meeker AK; Netto G; De Marzo AM; Nelson WG; Yegnasubramanian S
    Nat Genet; 2010 Aug; 42(8):668-75. PubMed ID: 20601956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
    Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
    Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.
    Lyons LS; Burnstein KL
    Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.
    Daniels G; Li Y; Gellert LL; Zhou A; Melamed J; Wu X; Zhang X; Zhang D; Meruelo D; Logan SK; Basch R; Lee P
    Endocr Relat Cancer; 2014 Feb; 21(1):127-42. PubMed ID: 24243687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells.
    Mayeur GL; Kung WJ; Martinez A; Izumiya C; Chen DJ; Kung HJ
    J Biol Chem; 2005 Mar; 280(11):10827-33. PubMed ID: 15640154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
    Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin.
    Chen ST; Okada M; Nakato R; Izumi K; Bando M; Shirahige K
    J Biol Chem; 2015 Aug; 290(35):21713-23. PubMed ID: 26175158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP.
    Mita P; Savas JN; Djouder N; Yates JR; Ha S; Ruoff R; Schafler ED; Nwachukwu JC; Tanese N; Cowan NJ; Zavadil J; Garabedian MJ; Logan SK
    Mol Cell Biol; 2011 Sep; 31(17):3639-52. PubMed ID: 21730289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.